NCT00208559View on ClinicalTrials.gov

Ziprasidone in Children With Autism: A Pilot Study

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

June 30, 2005

Study Completion Date

August 31, 2006

Conditions
Autism
Interventions
DRUG

Ziprasidone

Ziprasidone 40mg to 60mg per day, individually titrated

Trial Locations (1)

19124

Drexel University College of Medicine at Friends Hospital, Philadelphia

All Listed Sponsors
lead

Drexel University College of Medicine

OTHER

NCT00208559 - Ziprasidone in Children With Autism: A Pilot Study | Biotech Hunter | Biotech Hunter